Publications by authors named "I Aftab"
Introduction: Presbyopia, difficulty in seeing close-ups, affects a billion people globally. Mobile financial services (MFS) have been mandated since January 2021 for Bangladesh government social safety net payments, including old age allowance (OAA) and widow allowance (WA). We report the protocol for the Transforming Households with Refraction and Innovative Financial Technology randomised trial assessing the impact on the use of online banking of providing presbyopic safety net beneficiaries with reading glasses, and brief smartphone and mobile banking app training.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to assess how effective mecillinam is against Enterobacterales that produce extended spectrum beta-lactamases (ESBL).
- A total of 120 ESBL-producing Enterobacterales isolates were analyzed, primarily from urine samples, with findings showing a significant sensitivity of 83% to mecillinam.
- The study concluded that mecillinam is effective against ESBL-producing bacteria, recommending further research with a larger sample size across different regions.
Article Synopsis
- Lactoferrin (LF) is an iron-binding glycoprotein with potential applications in treating various eye diseases, particularly those affecting the retina, cornea, and optic nerve.
- The retina is vulnerable to oxidative stress from light exposure, leading to conditions like retinitis pigmentosa and age-related macular degeneration, which are significant causes of vision loss.
- LF can be utilized in nano-formulations for drug delivery across the blood-retina barrier, showcasing antibacterial properties and involvement in cell cycle control, distinguishing it from other transferrin proteins.
Article Synopsis
- Rare diseases, particularly rare eye diseases, affect about 6%-8% of the population and pose significant public health challenges, particularly regarding diagnosis and treatment.
- Establishing registries for these rare conditions is essential to create a comprehensive database, which can support both patients and researchers.
- Currently, there are very few registries globally, with none in India, highlighting a critical gap in resources needed to study and manage these rare disorders.
Background: Elderly patients with COVID-19 disease are at increased risk for adverse outcomes. Current data regarding disease characteristics and outcomes in this population are limited.
Aim: To delineate the adverse factors associated with outcomes of COVID-19 patients ≥75 years of age.